VALENCIA, Calif. , May 7 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.

    -- Bank of America Health Care Conference on Wednesday, May 14, 2008 at
       8:40 AM (Pacific Time) at the Four Seasons Hotel, Las Vegas, Nevada
    -- Baird's 2008 Growth Stock Conference on Thursday, May 15, 2008 at
       8:55 AM (Central Time) at the Four Seasons Hotel, Chicago, Illinois
    -- UBS Global Specialty and Generic Pharmaceuticals Conference on
       Thursday, May 29, 2008 at 9:30 AM (London Time) at The Waldorf Hilton,
       Aldwych, London

Interested parties can access a link to the live web cast of the presentations in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of each presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States , Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.

SOURCE MannKind Corporation